Antibody - Biological warfare agents
Authors/Creators
- 1. Laboratoire Ecologie, Systématique et Evolution, Université Paris-Sud, UMR 8079 CNRS, AgroParisTech, F-91405 Orsay, France
- 2. Université Paul Sabatier, Laboratoire de Zoologie, Ecobiologie des Arthropodes édaphiques, 118 route de Narbonne, F-31062, Toulouse Cedex, France
Description
An antibody (Ab), also known as immunoglobulin (Ig), is a large Y-shape protein consisting of two heavy chains and two light chains (Figure 1) which form a functionally bivalent monomer that is produced by B cells receptor used by the immune system to identify and neutralize foreign objects such as bacteria and viruses. Current widely used rapid detection systems exploit antibodies for recognition, identification and quantification of target analytes [68]. Abs played an important role in the advancement of diagnostic assays, making these indispensable in diagnostic tests that are commonly used routinely in clinics in classical immunological methods such as ELISA, dot blot immunobinding assays, electro-chemiluminescence, flow cytometry and several microscopic techniques like fluorescence, as well as in the construction of numerous immunosensors. Immunoglobulin M (IgM) usually exists as a pentamer in mammals that predominates in primary immune responses to most antigens, and is the most efficient complement fixing immunoglobulin. It comprises approximately 10% of all normal human serum Ig content. IgM is mainly produced by the immune system for protection against numerous viral, bacterial, fungal and parasitic infections.
Files
WNOFNS 5 (2016) 1-19.pdf
Files
(907.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:de211898c0f5e1ffcce03a163da82bde
|
907.1 kB | Preview Download |
Additional details
Identifiers
Software
- Repository URL
- https://www.worldnewsnaturalsciences.com/
- Development Status
- Active
References
- [1] Frischknecht, F., The history of biological warfare. European Molecular Biology Organization, 2003. 4(Special issue): p. S47-S52.
- [2] Wheelis, M., Biological Warfare at the 1346 Siege of Caffa. Emerging Infectious Diseases, 2002. 8(9): p. 971-975.
- [3] Riedel, S., Biological warfare and bioterrorism: a historical review. Baylor University Medical Center Proceedings, 2004. 17(4): p. 400-406.
- [4] Metcalfe, N., A short history of biological warfare. Medicine, Conflict and Survival, 2002. 18(3): p. 271-282.
- [5] Roffey, R., Tegnell, A., and Elgh, F., Biological warfare in a historical perspective. Clinical Microbiology and Infection, 2002. 8(8): p. 450-454.
- [6] Pichtel, J., Terrorism and WMDs: Awareness and Response. CRC Press, Boca Raton, 2011: p. 127.
- [7] Willis, E.A., Seascape with monkeys and guinea-pigs: Britain's biological weapons research programme,1948–54. Medicine, Conflict and Survival, 2003. 19(4): p. 285-302.
- [8] Szinicz, L., History of chemical and biological warfare agents. Toxicology, 2005. 214: p. 167-181.
- [9] Roffey, R., Tegnell, A., and Elgh, F., Biological weapons and bioterrorism preparedness: importance of public-health awareness and international cooperation. Clinical Microbiology and Infection, 2002. 8(8): p. 522-528.
- [10] Millet, P.D., The Biological and Toxin Weapons Convention. Revue Scientifique Et Technique De L`Office Iinternational Des Epizooties, 2006. 25(1): p. 35-52.